The PRMT1-BTG2 complex modulates pre-B cell differentiation through the methylation of cyclin-dependent kinase 4 (CDK4), and the complex is also able to impair the pre-B acute lymphoid leukemia (ALL) induction [41]. This evidence concerns the gene PRMT1 and acute lymphoblastic leukemia.